EyePoint Pharmaceuticals Inc XNAS: EYPT

EyePoint Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Name: EyePoint Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: EyePoint Pharmaceuticals Inc
Rating: 0.867319375
Author: Trendlyne DVM scores

Weak Stock

Download real time

5.68 0.13 (2.34%)

73.28% Fall from 52W High

557.9K XNAS Volume

XNAS 17 Apr, 2025 5:30 PM (EDT)

Low Financial Strength

11.1 / 100

Expensive Valuation

15.8 / 100

Technically Bearish

31.3 / 100

Weak Stock These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

33

1Yr Price target upside is 481%

12 analysts

EyePoint Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

EyePoint Pharmaceuticals Inc FAQ

How is EyePoint Pharmaceuticals Inc today?

EyePoint Pharmaceuticals Inc today is trading in the green, and is up by 2.34% at 5.68.

How has EyePoint Pharmaceuticals Inc performed historically?

EyePoint Pharmaceuticals Inc is currently trading up 2.34% on an intraday basis. In the past week the stock rose 5.58%. stock has been down -24.06% in the past quarter and fell -67.54% in the past year. You can view this in the overview section.